Evidence map›Paper›PMID 28653034›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2017

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.

Nick van Wijk, Rosalinde E R Slot, Flora H Duits, Marieke Strik, Egbert Biesheuvel, John W C Sijben, Marinus A Blankenstein, Jörgen Bierau, Wiesje M van der Flier, Philip Scheltens and 1 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Parkinson disease is a fatty acidopathy.Nature reviews. Neurology · 2025
    Review
  3. The Role of Uridine in Health and Disease.Journal of inflammation research · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A metabolite panel that differentiates Alzheimer's disease from other dementia types.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Nick van WijkNutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, The Netherlands.
Rosalinde E R SlotAlzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Flora H DuitsAlzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Marieke StrikDepartment of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands.
Egbert BiesheuvelNutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, The Netherlands.
John W C SijbenNutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, The Netherlands.
Marinus A BlankensteinDepartment of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands.
Jörgen BierauDepartment of Clinical Genetics, Maastricht UMC+, Maastricht, The Netherlands.
Wiesje M van der FlierAlzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Philip ScheltensAlzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Charlotte E TeunissenDepartment of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands.
Amsterdam UMC Location VUmc · NLNutricia Research (Netherlands) · NLMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSynaptic membrane formation depends on nutrients that fuel metabolic pathways for the synthesis of constituent phospholipids. Consequently, insufficient availability of such nutrients may restrict membrane formation and contribute to synaptic dysfunction in Alzheimer's disease (AD). We assessed whether blood and cerebrospinal fluid (CSF) concentrations of nutrients related to phospholipid synthesis differ among patients with AD, mild cognitive impairment (MCI), and control subjects.

methodsConcentrations of uridine, choline, folate, homocysteine, and other related metabolites were analyzed in paired blood and CSF samples from subjects selected from the Amsterdam Dementia Cohort with AD (

resultsAge- and gender-adjusted analysis of variance revealed different concentrations of circulating uridine, choline, and folate and CSF uridine, folate, and homocysteine (all DISCUSSION: AD and MCI patients have lower levels of nutrients involved in phospholipid synthesis. The current observations warrant exploration of the application of nutritional strategies in the early stages of AD.

Indexed as

Alzheimer's diseaseBloodCerebrospinal fluidCholineFolateHomocysteineMild cognitive impairmentNutritional statusPhospholipid precursorsUridine

Identifiers

PMID28653034
PMCPMC5476966
OpenAlexW2614472650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.